Bringing art to MetroLink station

The Mildred Lane Kemper Art Museum has brought “How to Build a Universe that Falls Apart Two Days Later” (2014), by Danish artist Jakob Kolding, to the Skinker MetroLink station. The piece has been installed at the southwest entrance of the staton at the corner of Skinker Blvd. and Forest Park Parkway. It explores the gaps between how architectural spaces are planned and how they’re actually used, consists of protest-style posters, pasted to the wall in variable configurations.

Media Advisory: Mummies receive CT scans at Washington University

Three Egyptian mummies journeyed Sunday from their home at the Saint Louis Art Museum to the campus of Washington University School of Medicine in St. Louis and Barnes-Jewish Hospital to be examined in a state-of-the-art computerized tomography (CT) scanner. CT scans — sometimes referred to as CAT scans — use special equipment that emits a […]

Washington People: Sean Joe

A Q&A with Sean Joe, PhD, the Benjamin E. Youngdahl Professor of Social Development at the Brown School, who came to Washington University in St. Louis this fall from the University of Michigan. His research focuses on black adolescents’ mental health; the role of religion in black suicidal behavior; and the development of father-focused, family-based interventions to prevent black adolescent males from engaging in multiple forms of self-destructive behaviors.

Knese receives NSF grant for math research

Gregory Knese, PhD, assistant professor of mathematics in Arts & Sciences, has been awarded a $138,000 grant from the National Science Foundation for his project “Harmonic Analysis and Spaces of Analytic Functions in Several Variables.”

Two teams win inaugural Global Impact Award

Nanopore Diagnostics and ViFlex are the inaugural winners of the Suren G. Dutia and Jas K. Grewal Global Impact Award from the Skandalaris Center for Entrepreneurial Studies at Washington University in St. Louis. Tom Cohen (right) and Nanopore are developing a test to better tailor antibiotics, and ViFlex is working on low-cost eyeglasses for developing countries.

The dwindling stock of antibiotics, and what to do about it

Pharmaceutical companies have largely abandoned the business of discovering and developing antibiotics and our stock of these “miracle drugs” is beginning to shrink. Michael Kinch and his colleagues at Washington University in St. Louis are working to create new models for drug discovery that could replace the failed private enterprise model.